Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017

R Ciccocioppo, CC Dos Santos, DC Baumgart, GC Cangemi, Vincenzo Cardinale, C Ciacci, P De Coppi, D Haldar, C Klersy, MC Nostro, M Ott, L Piemonti, AA Tomei, B Uygun, S Vetrano, G. Orlando

Research output: Contribution to journalArticle

Abstract

A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies. © 2017 International Society for Cellular Therapy
Original languageEnglish
Pages (from-to)461-476
Number of pages16
JournalCytotherapy
Volume20
Issue number3
DOIs
Publication statusPublished - 2018

Fingerprint

Regenerative Medicine
Therapeutics
Diabetes Mellitus
Medicine
Technology
Safety
United Kingdom
Liver

Cite this

Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017. / Ciccocioppo, R; Dos Santos, CC; Baumgart, DC; Cangemi, GC; Cardinale, Vincenzo; Ciacci, C; De Coppi, P; Haldar, D; Klersy, C; Nostro, MC; Ott, M; Piemonti, L; Tomei, AA; Uygun, B; Vetrano, S; Orlando, G.

In: Cytotherapy, Vol. 20, No. 3, 2018, p. 461-476.

Research output: Contribution to journalArticle

Ciccocioppo, R, Dos Santos, CC, Baumgart, DC, Cangemi, GC, Cardinale, V, Ciacci, C, De Coppi, P, Haldar, D, Klersy, C, Nostro, MC, Ott, M, Piemonti, L, Tomei, AA, Uygun, B, Vetrano, S & Orlando, G 2018, 'Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017', Cytotherapy, vol. 20, no. 3, pp. 461-476. https://doi.org/10.1016/j.jcyt.2017.12.004
Ciccocioppo, R ; Dos Santos, CC ; Baumgart, DC ; Cangemi, GC ; Cardinale, Vincenzo ; Ciacci, C ; De Coppi, P ; Haldar, D ; Klersy, C ; Nostro, MC ; Ott, M ; Piemonti, L ; Tomei, AA ; Uygun, B ; Vetrano, S ; Orlando, G. / Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017. In: Cytotherapy. 2018 ; Vol. 20, No. 3. pp. 461-476.
@article{77def90033b34becb14b44ad28cd0737,
title = "Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017",
abstract = "A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies. {\circledC} 2017 International Society for Cellular Therapy",
author = "R Ciccocioppo and {Dos Santos}, CC and DC Baumgart and GC Cangemi and Vincenzo Cardinale and C Ciacci and {De Coppi}, P and D Haldar and C Klersy and MC Nostro and M Ott and L Piemonti and AA Tomei and B Uygun and S Vetrano and G. Orlando",
year = "2018",
doi = "10.1016/j.jcyt.2017.12.004",
language = "English",
volume = "20",
pages = "461--476",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017

AU - Ciccocioppo, R

AU - Dos Santos, CC

AU - Baumgart, DC

AU - Cangemi, GC

AU - Cardinale, Vincenzo

AU - Ciacci, C

AU - De Coppi, P

AU - Haldar, D

AU - Klersy, C

AU - Nostro, MC

AU - Ott, M

AU - Piemonti, L

AU - Tomei, AA

AU - Uygun, B

AU - Vetrano, S

AU - Orlando, G.

PY - 2018

Y1 - 2018

N2 - A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies. © 2017 International Society for Cellular Therapy

AB - A summary of the First Signature Series Event, “Advancements in Cellular Therapies and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London, United Kingdom, is presented. Twelve speakers from three continents covered major topics in the areas of cellular therapy and regenerative medicine applied to liver and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their presentations, together with an overview of the global impact of digestive diseases and a proposal for a shared online collection and data-monitoring platform tool, are included in this proceedings. Although growing evidence demonstrate the feasibility and safety of exploiting cell-based technologies for the treatment of digestive diseases, regulatory and methodological obstacles will need to be overcome before the successful implementation in the clinic of these novel attractive therapeutic strategies. © 2017 International Society for Cellular Therapy

U2 - 10.1016/j.jcyt.2017.12.004

DO - 10.1016/j.jcyt.2017.12.004

M3 - Article

VL - 20

SP - 461

EP - 476

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 3

ER -